Nikolaos P. Nanis - 01 Mar 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: Chief Technology Officer
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 01 Mar 2024
Net transactions value: -$41,603
Form type: 4
Filing time: 05 Mar 2024, 16:09:12 UTC
Previous filing: 04 Jan 2024
Next filing: 20 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+1,479	+2.3%		66,510	01 Mar 2024	Direct	F1
transaction	TDOC	Common Stock	Options Exercise		+505	+0.76%		67,015	01 Mar 2024	Direct	F2
transaction	TDOC	Common Stock	Options Exercise		+894	+1.3%		67,909	01 Mar 2024	Direct	F2
transaction	TDOC	Common Stock	Options Exercise		+4,340	+6.4%		72,249	01 Mar 2024	Direct	F2
transaction	TDOC	Common Stock	Options Exercise		+467	+0.65%		72,716	01 Mar 2024	Direct	F2
transaction	TDOC	Common Stock	Sale	$41,603	-2,866	-3.9%	$14.52	69,850	04 Mar 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Performance Stock Units	Award	$0	+4,437		$0.000000	4,437	01 Mar 2024	Common Stock	4,437		Direct	F4, F5, F6
transaction	TDOC	Performance Stock Units	Options Exercise	$0	-1,479	-33%	$0.000000	2,958	01 Mar 2024	Common Stock	1,479		Direct	F1, F7
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-505	-20%	$0.000000	2,023	01 Mar 2024	Common Stock	505		Direct	F2, F8
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-894	-17%	$0.000000	4,472	01 Mar 2024	Common Stock	894		Direct	F2, F9
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-4,340	-33%	$0.000000	8,681	01 Mar 2024	Common Stock	4,340		Direct	F2, F10
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-467	-100%	$0.000000^*	0	01 Mar 2024	Common Stock	467		Direct	F2, F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4	Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F5	Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
F6	The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7	On March 1, 2024, the reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8	On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F9	On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F10	On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F11	On March 2, 2021, the reporting person was granted 1,400 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.